The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Andreas Billich

Dermatology & Immunopathology

Novartis Institute for Biomedical Research Vienna




Name/email consistency: high



  • Dermatology & Immunopathology, Novartis Institute for Biomedical Research Vienna, Vienna, Austria. 2004 - 2005
  • Novartis Research Institute, General Dermatology, PO Box 80, Brunner Strasse 59, Austria. 1998 - 2004


  1. Novel cyclosporin derivatives featuring enhanced skin penetration despite increased molecular weight. Billich, A., Vyplel, H., Grassberger, M., Schmook, F.P., Steck, A., Stuetz, A. Bioorg. Med. Chem. (2005) [Pubmed]
  2. Basal and induced sphingosine kinase 1 activity in A549 carcinoma cells: function in cell survival and IL-1beta and TNF-alpha induced production of inflammatory mediators. Billich, A., Bornancin, F., Mechtcheriakova, D., Natt, F., Huesken, D., Baumruker, T. Cell. Signal. (2005) [Pubmed]
  3. Percutaneous absorption of drugs used in atopic eczema: pimecrolimus permeates less through skin than corticosteroids and tacrolimus. Billich, A., Aschauer, H., Aszódi, A., Stuetz, A. Int. J. Pharm (2004) [Pubmed]
  4. Fluorescence-based assay of sphingosine kinases. Billich, A., Ettmayer, P. Anal. Biochem. (2004) [Pubmed]
  5. AIDSVAX VaxGen. Billich, A. Curr. Opin. Investig. Drugs (2004) [Pubmed]
  6. Confocal fluorescence detection expanded to UV excitation: the first continuous fluorimetric assay of human steroid sulfatase in nanoliter volume. Billich, A., Bilban, M., Meisner, N.C., Nussbaumer, P., Neubauer, A., Jäger, S., Auer, M. Assay. Drug. Dev. Technol (2004) [Pubmed]
  7. 6-[2-(adamantylidene)-hydroxybenzoxazole]-O-sulfamate, a steroid sulfatase inhibitor for the treatment of androgen- and estrogen-dependent diseases. Billich, A., Meingassner, J.G., Nussbaumer, P., Desrayaud, S., Lam, C., Winiski, A., Schreiner, E. J. Steroid Biochem. Mol. Biol. (2004) [Pubmed]
  8. HPV vaccine MedImmune/GlaxoSmithKline. Billich, A. Curr. Opin. Investig. Drugs (2003) [Pubmed]
  9. Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases. Billich, A., Bornancin, F., Dévay, P., Mechtcheriakova, D., Urtz, N., Baumruker, T. J. Biol. Chem. (2003) [Pubmed]
  10. Thymosin alpha1. SciClone Pharmaceuticals. Billich, A. Curr. Opin. Investig. Drugs (2002) [Pubmed]
  11. Entecavir (Bristol-Myers Squibb). Billich, A. Curr. Opin. Investig. Drugs (2001) [Pubmed]
  12. AIDSVAX. VaxGen. Billich, A. Curr. Opin. Investig. Drugs (2001) [Pubmed]
  13. Stimulation of MCF-7 breast cancer cell proliferation by estrone sulfate and dehydroepiandrosterone sulfate: inhibition by novel non-steroidal steroid sulfatase inhibitors. Billich, A., Nussbaumer, P., Lehr, P. J. Steroid Biochem. Mol. Biol. (2000) [Pubmed]
  14. Technology evaluation: FluMist, University of Michigan. Billich, A. Curr. Opin. Mol. Ther. (2000) [Pubmed]
  15. Pleconaril Sanofi Synthélabo/ViroPharma. Billich, A. Curr. Opin. Investig. Drugs (2000) [Pubmed]
  16. Amprenavir (Vertex Pharmaceuticals Inc). Billich, A. IDrugs (1999) [Pubmed]
  17. GS-4104 (Gilead Sciences Inc). Billich, A. IDrugs (1998) [Pubmed]
WikiGenes - Universities